2016
DOI: 10.4103/2277-9175.187404
|View full text |Cite
|
Sign up to set email alerts
|

Effect of add-on valproate on craving in methamphetamine depended patients: A randomized trial

Abstract: Background:Methamphetamine dependence lead to the compulsive use, loss of control, and social and occupational dysfunctions. This study aimed to compare the effect of valproate in reducing the craving in methamphetamine dependents.Materials and Methods:This is a randomized, double-blind, controlled clinical trial on 40 men of 18–40 years old referred to Noor Hospital during December 2012–September 2013 in Isfahan, Iran. The subjects participated in matrix program and randomly were divided into two groups of va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Substance use disorder is a chronic illness, therefore, continuous and feasible system of delivery of care and also long-term monitoring for maintenance of recovery should be prepared for an efficacious treatment outcome. [ 48 49 ] Militaries must use evidence-based therapies for substance use related disorders. It could be a challenge for treatment providers and also policy makers because although researches demonstrates the effectiveness of evidence-based treatments, many practitioners do not use these treatments routinely or select eclectic approaches.…”
Section: Resultsmentioning
confidence: 99%
“…Substance use disorder is a chronic illness, therefore, continuous and feasible system of delivery of care and also long-term monitoring for maintenance of recovery should be prepared for an efficacious treatment outcome. [ 48 49 ] Militaries must use evidence-based therapies for substance use related disorders. It could be a challenge for treatment providers and also policy makers because although researches demonstrates the effectiveness of evidence-based treatments, many practitioners do not use these treatments routinely or select eclectic approaches.…”
Section: Resultsmentioning
confidence: 99%
“…Valproate [64], Buprenorphine [75], Dexamphetamine [67], Varenicline [26]), were favored to placebo, with the exception of Gabapentin [61] and Ibudilast [63].…”
Section: Feasibility Assessment: Network Meta-analysismentioning
confidence: 99%